Registro:

Referencias:

• Docampo, R., Cruz, F.S., Boveris, A., Muniz, R.P., Esquivel, D.M., β-Lapachone enhancement of lipid peroxidation and superoxide anion and hydrogen peroxide formation by sarcoma 180 ascites tumor cells (1979) Biochem Pharmacol, 28, pp. 723-728
• Santana, C.F., Lima, O.G., D'Alburquerque, I.L., Lacerda, A.L., Martins, D.G., (1968) Revta Inst Antibiot Univ Recife, p. 8
• Schaffner-Sabba, K., Schmidt-Ruppin, K.H., Wehrli, W., Schuerch, A.R., Wasley, J.W., β-Lapachone: Synthesis of derivatives and activities in tumor models (1984) J Med Chem, 27, pp. 990-994
• Chau, Y.P., Shiah, S.G., Don, M.J., Kuo, M.L., Involvement of hydrogen peroxide in topoisomerase inhibitor β-lapachone-induced apoptosis and differentiation in human leukemia cells (1998) Free Radic Biol Med, 24, pp. 660-670
• Dolan, M.E., Frydman, B., Thompson, C.B., Effects of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agents (1998) Anticancer Drugs, 9, pp. 437-448
• Pink, J.J., Planchon, S.M., Tagliarino, C., NAD(P)H: Quinone oxidoreductase activity is the principal determinant of β-lapachone cytotoxicity (2000) J Biol Chem, 275, pp. 5416-5424
• Robertson, N., Haigh, A., Adams, G.E., Stratford, I.J., Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxia (1994) Eur J Cancer, 7, pp. 1013-1019
• Cadenas, E., Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism (1995) Biochem Pharmacol, 49, pp. 127-140
• Ross, D., Beall, H., Traver, R.D., Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies (1994) Oncol Res, 6, pp. 493-500
• Rauth, A.M., Goldberg, Z., Misra, V., DT-diaphorase: Possible roles in cancer chemotherapy and carcinogenesis (1997) Oncol Res, 9, pp. 339-349
• Ross, D., Siegel, D., Beall, H., DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C (1993) Cancer Metastasis Rev, 12, pp. 83-101
• Boothman, D.A., Meyers, M., Fukunaga, N., Lee, S.W., Isolation of X-ray-inducible transcripts from radioresistant human melanoma cells (1993) Proc Natl Acad Sci U S A, 90, pp. 7200-7204
• Wuerzberger, S.M., Pink, J.J., Planchon, S.M., Induction of apoptosis in MCF-7:WS8 breast cancer cells by β-lapachone (1998) Cancer Res, 58, pp. 1876-1885
• Kaufmann, S.H., Vaux, D.L., Alterations in the apoptotic machinery and their potential role in anticancer drug resistance (2003) Oncogene, 22, pp. 7414-7430
• Novotny, L., Szekeres, T., Cancer therapy: New targets for chemotherapy (2003) Hematology, 8, pp. 129-137
• Pink, J.J., Wuerzberger-Davis, S., Tagliarino, C., Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during β-lapachone-mediated apoptosis (2000) Exp Cell Res, 255, pp. 144-155
• Planchon, S.M., Wuerzberger, S., Frydman, B., β-Lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: A p53-independent response (1995) Cancer Res, 55, pp. 3706-3711
• Tagliarino, C., Pink, J.J., Reinicke, K.E., μ-Calpain activation in β-lapachone-mediated apoptosis (2003) Cancer Biol Ther, 2, pp. 141-152
• Tagliarino, C., Pink, J.J., Dubyak, G.R., Nieminen, A.L., Boothman, D.A., Calcium is a key signaling molecule in β-lapachone-mediated cell death (2001) J Biol Chem, 276, pp. 19150-19159
• Tagliarino, C., Pink, J.J., Boothman, D.A., Calpains and apoptosis (2001) Korean J Biol Sci, 5, pp. 267-274
• Marin, A., Lopez De Cerain, A., Hamilton, E., DT-diaphorase and cytochrome B5 reductase in human lung and breast tumours (1997) Br J Cancer, 76, pp. 923-929
• Malkinson, A.M., Siegel, D., Forrest, G.L., Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: Relationship to the response of lung tumor xenografts to mitomycin Cl (1992) Cancer Res, 52, pp. 4752-4757
• Belinsky, M., Jaiswal, A.K., NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues (1993) Cancer Metastasis Rev, 12, pp. 103-117
• Joseph, P., Xie, T., Xu, Y., Jaiswal, A.K., NAD(P)H:quinone oxidoreductase1 (DT-diaphorase): Expression, regulation, and role in cancer (1994) Oncol Res, 6, pp. 525-532
• Boothman, D.A., Pardee, A.B., Inhibition of radiation-induced neoplastic transformation by β-lapachone (1989) Proc Natl Acad Sci U S A, 86, pp. 4963-4967
• Yao, K., Peng, T., Xu, M., pH-dependent hydrolysis and drug release of chitosan/polyether interpenetrating polymer network hydrogel (1994) Polym Int, 34, pp. 213-219
• Page, M.I., Reactions of aldehydes and ketones and their derivatives (1996) Organic Reaction Mechanisms, pp. 1-17
• Hoffman, A.S., Saito, H., Harris, J.M., Drug delivery from biodegradable PEG hydrogels with Schiff base linkages (1997) Proc Int Symp Controlled Release Bioactive Mater, 24, pp. 565-566
• Solovskii, M.V., Nikol'skaya, N.V., Zaikina, N.A., Synthesis and properties of polymeric Schiff bases of the antibiotic spiramycin (2002) Pharm Chem J, 36, pp. 61-65
• Nishi, K.K., Jayakrishnan, A., Preparation and in vitro evaluation of primaquine-conjugated gum arable microspheres (2004) Biomacromolecules, 5, pp. 1489-1495
• Di Chenna, P.H., Benedetti-Doctorovich, V., Baggio, R.F., Garland, M.T., Burton, G., Preparation and cytotoxicity toward cancer cells of mono(arylimino) derivatives of β-lapachone (2001) J Med Chem, 44, pp. 2486-2489
• Planchon, S.M., Pink, J.J., Tagliarino, C., β-Lapachone-induced apoptosis in human prostate cancer cells: Involvement of NQO1/xip3 (2001) Exp Cell Res, 267, pp. 95-106
• Li, C., Jackson, R.M., Reactive species mechanisms of cellular hypoxia-reoxygenation injury (2002) Am J Physiol Cell Physiol, 282, pp. C227-41
• Hollander, P.M., Bartfai, T., Gatt, S., Studies on the reaction mechanism of DT diaphorase. Intermediary plateau and trough regions in the initial velocity vs substrate concentration curves (1975) Arch Biochem Biophys, 169, pp. 568-576
• Ochi, T., Menadione causes increases in the level of glutathione and in the activity of γ-glutamylcysteine synthetase in cultured Chinese hamster V79 cells (1996) Toxicology, 112, pp. 45-55
• Pardee, A.B., Li, Y.Z., Li, C.J., Cancer therapy with β-lapachone (2002) Curr Cancer Drug Targets, 2, pp. 227-242
• Dubin, M., Fernandez Villamil, S.H., Stoppant, A.O., Cytotoxicity of β-lapachone, an naphthoquinone with possible therapeutic use (2001) Medicina, 61, pp. 343-350. , B Aires
• Shiah, S.G., Chuang, S.E., Chau, Y.P., Shen, S.C., Kuo, M.L., Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor β-lapachone-induced apoptosis through an oxidation-dependent pathway (1999) Cancer Res, 59, pp. 391-398
• Misico, R.I., Forzani, E.S., Measurement of hydrolysis decay time constants of monoarylimino derivatives of β-lapachone through cyclic voltammetry (2003) Electrochem Commun, 5, pp. 449-454
• Engin, K., Leeper, D.B., Cater, J.R., Extracellular pH distribution in human tumours (1995) Int J Hyperthermia, 11, pp. 211-216
• Stubbs, M., McSheehy, P.M., Griffiths, J.R., Bashford, C.L., Causes and consequences of tumour acidity and implications for treatment (2000) Mol Med Today, 6, pp. 15-19
• Loeffler, D.A., Juneau, P.L., Heppner, G.H., Natural killer-cell activity under conditions reflective of tumor microenvironment (1991) Int J Cancer, 48, pp. 895-899
• Oliveira-Brett, A.M., Goulart, M.O., Abreu, F.C., Reduction of lapachones and their reaction with L-cysteine and mercaptoethanol on glassy carbon electrodes (2002) Bioelectrochemistry, 56, pp. 53-55
• Chen, S., Knox, R., Lewis, A.D., Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: Study involving mouse, rat, human, and mouse-rat chimeric enzymes (1995) Mol Pharmacol, 47, pp. 934-939
• Jaiswal, A.K., McBride, O.W., Adesnik, M., Nebert, D.W., Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16 (1988) J Biol Chem, 263, pp. 13572-13578
• Atsumi, R., Okazaki, O., Hakusui, H., Pharmacokinetics of SN-38 [(+)-(4S)-4,11-diethyl-4,9-dihydroxy-1H- pyrano[3′,4′:6,7]-indolizino[1,2-b]quinoline-3, 14(4H,12H)-dione], an active metabolite of irinotecan, after a single intravenous dosing of 14C-SN-38 to rats (1995) Biol Pharm Bull, 18, pp. 1114-1119

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------